Withdrawn from the Canadian, US, and UK markets in 1963 due to interactions with food products containing tyrosine.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Nialamide. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Nialamide. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nialamide. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nialamide. |
| Magnesium sulfate | The therapeutic efficacy of Nialamide can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Nialamide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Nialamide may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Nialamide. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Nialamide. |
| Orphenadrine | Nialamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Nialamide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Nialamide. |
| Pramipexole | Nialamide may increase the sedative activities of Pramipexole. |
| Ropinirole | Nialamide may increase the sedative activities of Ropinirole. |
| Rotigotine | Nialamide may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Nialamide. |
| Sodium oxybate | Nialamide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Nialamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Thalidomide | Nialamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Nialamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Desmopressin | The risk or severity of hypertension can be increased when Desmopressin is combined with Nialamide. |
| Cyclosporine | The risk or severity of hypertension can be increased when Cyclosporine is combined with Nialamide. |
| Icosapent | The risk or severity of hypertension can be increased when Icosapent is combined with Nialamide. |
| Mesalazine | The risk or severity of hypertension can be increased when Mesalazine is combined with Nialamide. |
| Indomethacin | The risk or severity of hypertension can be increased when Indomethacin is combined with Nialamide. |
| Methylergometrine | The risk or severity of hypertension can be increased when Methylergometrine is combined with Nialamide. |
| Nabumetone | The risk or severity of hypertension can be increased when Nabumetone is combined with Nialamide. |
| Ketorolac | The risk or severity of hypertension can be increased when Ketorolac is combined with Nialamide. |
| Tenoxicam | The risk or severity of hypertension can be increased when Tenoxicam is combined with Nialamide. |
| Celecoxib | The risk or severity of hypertension can be increased when Celecoxib is combined with Nialamide. |
| Tolmetin | The risk or severity of hypertension can be increased when Tolmetin is combined with Nialamide. |
| Rofecoxib | The risk or severity of hypertension can be increased when Rofecoxib is combined with Nialamide. |
| Piroxicam | The risk or severity of hypertension can be increased when Piroxicam is combined with Nialamide. |
| Fenoprofen | The risk or severity of hypertension can be increased when Fenoprofen is combined with Nialamide. |
| Valdecoxib | The risk or severity of hypertension can be increased when Valdecoxib is combined with Nialamide. |
| Diclofenac | The risk or severity of hypertension can be increased when Diclofenac is combined with Nialamide. |
| Sulindac | The risk or severity of hypertension can be increased when Sulindac is combined with Nialamide. |
| Nicergoline | The risk or severity of hypertension can be increased when Nicergoline is combined with Nialamide. |
| Flurbiprofen | The risk or severity of hypertension can be increased when Flurbiprofen is combined with Nialamide. |
| Etodolac | The risk or severity of hypertension can be increased when Etodolac is combined with Nialamide. |
| Mefenamic acid | The risk or severity of hypertension can be increased when Mefenamic acid is combined with Nialamide. |
| Naproxen | The risk or severity of hypertension can be increased when Naproxen is combined with Nialamide. |
| Sulfasalazine | The risk or severity of hypertension can be increased when Sulfasalazine is combined with Nialamide. |
| Phenylbutazone | The risk or severity of hypertension can be increased when Phenylbutazone is combined with Nialamide. |
| Meloxicam | The risk or severity of hypertension can be increased when Meloxicam is combined with Nialamide. |
| Carprofen | The risk or severity of hypertension can be increased when Carprofen is combined with Nialamide. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Nialamide. |
| Diflunisal | The risk or severity of hypertension can be increased when Diflunisal is combined with Nialamide. |
| Salicylic acid | The risk or severity of hypertension can be increased when Salicylic acid is combined with Nialamide. |
| Meclofenamic acid | The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Nialamide. |
| Dopamine | The risk or severity of hypertension can be increased when Dopamine is combined with Nialamide. |
| Oxaprozin | The risk or severity of hypertension can be increased when Oxaprozin is combined with Nialamide. |
| Ketoprofen | The risk or severity of hypertension can be increased when Ketoprofen is combined with Nialamide. |
| Balsalazide | The risk or severity of hypertension can be increased when Balsalazide is combined with Nialamide. |
| Ibuprofen | The risk or severity of hypertension can be increased when Ibuprofen is combined with Nialamide. |
| Dutasteride | The risk or severity of hypertension can be increased when Dutasteride is combined with Nialamide. |
| Propafenone | The risk or severity of hypertension can be increased when Propafenone is combined with Nialamide. |
| Finasteride | The risk or severity of hypertension can be increased when Finasteride is combined with Nialamide. |
| Lumiracoxib | The risk or severity of hypertension can be increased when Lumiracoxib is combined with Nialamide. |
| Ephedrine | The risk or severity of hypertension can be increased when Ephedrine is combined with Nialamide. |
| Magnesium salicylate | The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Nialamide. |
| Salsalate | The risk or severity of hypertension can be increased when Salsalate is combined with Nialamide. |
| Choline magnesium trisalicylate | The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Nialamide. |
| Antrafenine | The risk or severity of hypertension can be increased when Antrafenine is combined with Nialamide. |
| Aminophenazone | The risk or severity of hypertension can be increased when Aminophenazone is combined with Nialamide. |
| Antipyrine | The risk or severity of hypertension can be increased when Antipyrine is combined with Nialamide. |
| Tiaprofenic acid | The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Nialamide. |
| Etoricoxib | The risk or severity of hypertension can be increased when Etoricoxib is combined with Nialamide. |
| Epicaptopril | The risk or severity of hypertension can be increased when Epicaptopril is combined with Nialamide. |
| Taxifolin | The risk or severity of hypertension can be increased when Taxifolin is combined with Nialamide. |
| Oxyphenbutazone | The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Nialamide. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Nialamide. |
| Benoxaprofen | The risk or severity of hypertension can be increased when Benoxaprofen is combined with Nialamide. |
| Metamizole | The risk or severity of hypertension can be increased when Metamizole is combined with Nialamide. |
| Zomepirac | The risk or severity of hypertension can be increased when Nialamide is combined with Zomepirac. |
| Dronedarone | The risk or severity of hypertension can be increased when Nialamide is combined with Dronedarone. |
| Cimicoxib | The risk or severity of hypertension can be increased when Nialamide is combined with Cimicoxib. |
| Amibegron | The risk or severity of hypertension can be increased when Nialamide is combined with Amibegron. |
| Nylidrin | The risk or severity of hypertension can be increased when Nialamide is combined with Nylidrin. |
| Solabegron | The risk or severity of hypertension can be increased when Nialamide is combined with Solabegron. |
| Lornoxicam | The risk or severity of hypertension can be increased when Nialamide is combined with Lornoxicam. |
| Aceclofenac | The risk or severity of hypertension can be increased when Nialamide is combined with Aceclofenac. |
| Zaltoprofen | The risk or severity of hypertension can be increased when Nialamide is combined with Zaltoprofen. |
| Saralasin | The risk or severity of hypertension can be increased when Nialamide is combined with Saralasin. |
| Azapropazone | The risk or severity of hypertension can be increased when Nialamide is combined with Azapropazone. |
| Parecoxib | The risk or severity of hypertension can be increased when Nialamide is combined with Parecoxib. |
| Salicylamide | The risk or severity of hypertension can be increased when Nialamide is combined with Salicylamide. |
| Tyramine | The risk or severity of hypertension can be increased when Nialamide is combined with Tyramine. |
| Mirabegron | The risk or severity of hypertension can be increased when Nialamide is combined with Mirabegron. |
| Adrafinil | The risk or severity of hypertension can be increased when Nialamide is combined with Adrafinil. |
| Kebuzone | The risk or severity of hypertension can be increased when Nialamide is combined with Kebuzone. |
| Isoxicam | The risk or severity of hypertension can be increased when Nialamide is combined with Isoxicam. |
| Indoprofen | The risk or severity of hypertension can be increased when Nialamide is combined with Indoprofen. |
| Ibuproxam | The risk or severity of hypertension can be increased when Nialamide is combined with Ibuproxam. |
| Floctafenine | The risk or severity of hypertension can be increased when Nialamide is combined with Floctafenine. |
| Fenbufen | The risk or severity of hypertension can be increased when Nialamide is combined with Fenbufen. |
| Etofenamate | The risk or severity of hypertension can be increased when Nialamide is combined with Etofenamate. |
| Etilefrine | The risk or severity of hypertension can be increased when Nialamide is combined with Etilefrine. |
| Epirizole | The risk or severity of hypertension can be increased when Nialamide is combined with Epirizole. |
| Benzydamine | The risk or severity of hypertension can be increased when Nialamide is combined with Benzydamine. |